Risk of somatic disease and mortality in individuals of parents with alcohol use disorder: a register‐based cohort study

Addiction ◽  
2021 ◽  
Author(s):  
Charlotte Holst ◽  
Janne S. Tolstrup ◽  
Ulrik Becker
Keyword(s):  
Cohort Study ◽  
Alcohol Use ◽  
Alcohol Use Disorder ◽  
Somatic Disease

Family structure and alcohol use disorder: a register‐based cohort study among offspring with and without parental alcohol use disorder

Addiction ◽  
2020 ◽  
Vol 115 (8) ◽  
pp. 1440-1449 ◽  
Author(s):  
Charlotte Holst ◽  
Janne S. Tolstrup ◽  
Holger J. Sørensen ◽  
Ulrik Becker
Keyword(s):  
Cohort Study ◽  
Alcohol Use ◽  
Family Structure ◽  
Alcohol Use Disorder ◽  
Parental Alcohol Use ◽  
Parental Alcohol

scholarly journals S1059 Treatment of Alcohol Use Disorder in Patients Admitted with Alcohol-Associated Liver Disease: A Retrospective Cohort Study

2021 ◽  
Vol 116 (1) ◽  
pp. S503-S503
Author(s):  
Patrick Twohig ◽  
Lauren Keim ◽  
Michelle Le ◽  
Nathalie Khoury ◽  
Wuttiporn Manatsathit ◽  
...  
Keyword(s):  
Cohort Study ◽  
Liver Disease ◽  
Alcohol Use ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Alcohol Use Disorder

scholarly journals Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada: A whole-population cohort study

PLoS ONE ◽  
2021 ◽  
Vol 16 (9) ◽  
pp. e0257025
Author(s):  
Geoffrey Konrad ◽  
Christine Leong ◽  
James M. Bolton ◽  
Heather J. Prior ◽  
Michael T. Paillé ◽  
...  
Keyword(s):  
Cohort Study ◽  
Anxiety Disorder ◽  
Alcohol Use ◽  
Administrative Data ◽  
Alcohol Use Disorder ◽  
Family Physicians ◽  
Rural Environment ◽  
Population Cohort ◽  
Canadian Population ◽  
Population Cohort Study

Objective Update the evidence on use of pharmacotherapy for alcohol use disorder in a Canadian population. Methods Using whole-population administrative data from Manitoba, Canada, we identified all residents age 12+ who were first diagnosed with alcohol use disorder between April 1, 1996 and March 31, 2015, and compared characteristics of those who filled a prescription for naltrexone, acamprosate or disulfiram at least once during that period to those who did not fill a prescription for an alcohol use disorder medication. Results Only 1.3% of individuals with alcohol use disorder received pharmacotherapy (62.3% of prescriptions were for naltrexone, 39.4% for acamprosate, 7.5% for disulfiram). Most prescriptions came from family physicians in urban alcohol use disorder (53.6%) and psychiatrists (22.3%). Individuals were more likely to fill a prescription for alcohol use disorder medication if they lived in an urban vs rural environment (OR 2.25; 95% CI 1.83–2.77) or had a mood/anxiety disorder diagnosis vs no diagnosis (OR 2.40, 95% CI 1.98–2.90) in the five years before being diagnosed with alcohol use disorder. Conclusion Despite established evidence for the effectiveness of pharmacotherapy for alcohol use disorder, these medications continue to be profoundly underutilized in Canada.

Sign in / Sign up

Export Citation Format

Share Document